Surgalign Holdings, Inc.

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

RTI Surgical - OEM Business designs, develops, manufactures and distributes biologic, metal and synthetic implants for a global customer base. Its implants are used in a variety of surgical procedures including orthopaedic, spine, sports medicine, general surgery and trauma.

DEERFIELD, Ill., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, today announced it plans to release financial results from the fourth quarter and full year 2020 after the close of trading on Thursday, March 11, 2021.

Surgalign Holdings Schedules Fourth Quarter and Full Year 2020 Earnings Call for March 11, 2021

DEERFIELD, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global surgical implant company (the “Company”), today announced that its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) will be held virtually on May 4, 2021 at 9:00 A.M. Central Time. Holders of record of the Company's common stock at the close of business on March 15, 2021, the record date, are entitled to notice of and to vote upon matters considered at the Annual Meeting.

Surgalign Holdings, Inc. Announces Record Date and Annual Meeting Date

Harley-Davidson

Texas Instruments

Alliance Data Systems

Bridge Bancorp

Brown & Brown

Evelo Biosciences Inc

MSC Industrial Direct

Outlook Therapeutics Inc

Vyne Therapeutics

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have been taking advantage of secondary offerings recently.

Notable Insider Buys Of The Past Week: Harley-Davidson, Texas Instruments And More

Sierra Bancorp

Chemung Financial

Cyclo Therapeutics, Inc.

Fastenal

Virios Therapeutics

Insider buying could be a bullish signal for a stock. Why? The insiders may sell for a number of reasons.

7 Stocks With Insider Buying

The stock price of Surgalign Holdings Inc (NASDAQ: SRGA) has increased by over 19% pre-market today as of 7:25 AM ET. This is why it happened.

SRGA Stock Price Increases Over 19% Pre-Market: Why It Happened

DEERFIELD, Ill., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA) (“Surgalign”), a global pure-play spine company focused on advancing the science of spine care by delivering innovative solutions, today announced the pricing of an underwritten public offering of 25,000,000 shares of its common stock at a price to the public of $1.50 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Surgalign. In addition, Surgalign has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of common stock at the public offering price, less the underwriting discount and commissions.

Surgalign Holdings, Inc. Announces Pricing of Public Offering of 25,000,000 Shares of its Common Stock

Commercial launch of ViBone® Moldable, a next generation moldable cellular bone matrix product in the US Commercial launch of ViBone® Moldable, a next generation moldable cellular bone matrix product in the US

Surgalign Holdings Announce the Commercial Launch of ViBone® Moldable and the First Clinical Implantation

DEERFIELD, Ill., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announced that the management team will participate in the 23rd Annual ICR/Westwicke Conference on Thursday, January 14, 2021.

Surgalign Holdings, Inc. to Participate at the 23rd Annual ICR/Westwicke Conference

Company is working off a solid base, and the balance sheet is clean. The technicals are ultra oversold especially on the long-term chart.

Surgalign Holdings : Strong Upside Potential

DEERFIELD, Ill., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced that the management team will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on Thursday, December 3, 2020. 

Surgalign Holdings, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

DEERFIELD, Ill., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announced the appointment of Paul Lewicki, PhD as a member of its board of directors.  With Dr. Lewicki's appointment the Surgalign Board now consists of nine directors. 

Surgalign Holdings, Inc. Appoints Paul Lewicki, PhD to Board of Directors

Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product

Surgalign Holdings and Aziyo Biologics Announce Expanded Distribution Agreement

DEERFIELD, Ill., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digital technologies to improve patient outcomes, today announced it plans to release financial results from the third quarter 2020 on Wednesday, November 11, 2020, after the market closes.

Surgalign Holdings, Inc. Schedules Third Quarter 2020 Earnings Release for November 11, 2020

DEERFIELD, Ill., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digital technologies to improve patient outcomes, today announced that it is changing its earnings release and conference call date for the third quarter 2020 as a result of a delay completing the financial statements due to the additional workload created by the recently completed sale of the OEM business and its classification as discontinued operations.

Surgalign Holdings, Inc. Announces Date Change for Third Quarter 2020 Earnings Release and Conference Call

ANI Pharma

Vanda Pharmaceuticals

PetMed Express

Surmodics

According to the GuruFocus All-in-One Screener as of Nov. 5, the following medical technology stocks are popular among gurus.

5 Medical Technology Stocks Popular Among Gurus

DEERFIELD, Ill., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digital technologies to improve patient outcomes, today announced its plans to release third quarter 2020 earnings and to host a virtual investor day.

Surgalign Holdings, Inc. Schedules Third Quarter 2020 Earnings Call for November 6 and Virtual Investor Day for November 12, 2020

Acquisition Delivers on Commitment to the Promise of Digital Surgery to Improve Patient Outcomes

Surgalign Holdings, Inc. Announces Completion of Acquisition of Holo Surgical Inc. and its ARAI Digital Surgery Platform

Commitment to the Promise of Digital Surgery to Improve Patient Outcomes Commitment to the Promise of Digital Surgery to Improve Patient Outcomes

Surgalign Holdings, Inc. Announces Agreement to Acquire Holo Surgical Inc. and its ARAI™ Digital Surgery Platform

News for Surgalign Holdings, Inc. Stock (SRGA)